A 67-year-old man was admitted to the acute care hospital from an otorhinolaryngology clinic on March 1, 2020 with stridor.
He had a squamous cell carcinoma of the hypopharynx, treated in 2015 with radiotherapy.
Emergency surgery was performed due to progressive obstruction of the airways.
CT scan and biopsy of the cystoscopy confirmed recurrence of the cancer.
The Australian Modified Karnofsky Index score was 70% at admission, but dropped to 40% during the process.
She was discharged to a more specialized palliative care residency.
On April 8, 2020 he was febrile (tympanic temperature 38.5 °C).
The next day it was positive in a test for COVID-19 by RT-PCR.
Oxygen therapy was applied due to peripheral capillary oxygen saturation (SpO2) 89%.
With the patient and family, a gradual plan of treatment for care in the ward was agreed.
On April 16, 2020, he presented tachypnea.
A chest X-ray showed typical features of COVID-19, with generalized bilateral ground glass opacities.
She was given a fentanyl patch (25 mcg/h) with premedication for dyspnea.
Despite oxygen therapy administered at 15 L/min via mask airway stenosis, the patient dislodged 79% SpO2 with a respiratory rate of 32 r.p.m.
He had a Glasgow coma scale of 3 points.
Median COVID-GRAM application was calculated as the probability of critical illness (ICU admission/intubation/death) in 99.3% at that time.
On April 19, 2020 he was referred to the palliative care team.
She received a continuous subcutaneous infusion of midazolam (10 mg), morphine (15 mg) and hyoscine (60 mg) over 24 hours.
The clinical impression was that he was in terminal condition.
They were contacted with their families to visit the hospital.
Treatment followed the individualized care plan «Priorities of Care».
The objective of care was the patient's well-being.
On April 16, 2020 he was more conscious.
However, his breathing was still tiring, so that morphine was increased to 35 mg/24 hours.
On April 29, 2020, the RT-PCR test remained positive for COVID-19.
With gradual clinical improvement, morphine was reduced to 20 mg/24 hours.
On May 4, 2020, continuous subcutaneous infusion was withdrawn.
Hydration and clinically directed nutrition were not administered when the patient was considered to be terminally ill.
A new blood test was performed on May 4, 2020, which revealed hypernatremia (154 mmol/L) and acute kidney injury (estimated glomerular filtration rate/min) decreased from > 90 mL/min to 42 mL.
Clinically directed nutrition and hydration were restarted.
On May 6, 2020, a final COVID-19 test was negative.
Her respiratory activity returned to the initial situation and was subsequently discharged to a residence.
